Yeruusaalem, 18 May, 2026 (TPS-IL) — Shirkadda Artivion, Inc. ee Maraykanka ka dhisan ayaa ku dhawaaqday inay dhammaystirtay helitaanka shirkadda qalabka caafimaadka ee Israa‘iil ee Endospan Ltd. oo ku kacday $135 milyan, taasoo hormuud u ah dayactirka endovascular ee cudurrada laamaha weyn ee dhiigga (aortic arch disease). Heshiiskan ayaa yimid ka dib iskaashi muddo dheer ah kaas oo Artivion u ahaa qaybiyaha keliya ee Endospan ee gobolka EMEA tan iyo 2019. Shirkaddu waxay sheegtay in helitaankani uu xoojinayo faylalka ay ka haystaan laamaha weyn ee dhiigga ka dib markii Hay’adda Cuntada iyo Dawooyinka ee Maraykanka (FDA) ay ansixisay nidaamka NEXUS ee Endospan bishii Abriil 2026.
Warbixin Degdeg ah
Shirkadda Artivion ee Maraykanka oo dhammaystiray $135M oo ah Iibsashada Endospan ee Israa’iil
Shirkadda Artivion, Inc. ayaa $135 milyan ku iibsatay Endospan Ltd. oo ahayd shirkad Israa'iili ah, taasoo kordhisay bixinta adeegyadeeda dayactirka xididada wadnaha kadib markii hay'adda FDA ay ansixisay nidaamka NEXUS ee Endospan.